Stem Cell Therapy For Lungs Disease

Adult stem cell therapy for chronic obstructive pulmonary disease and damaged lungs is now possible via lung bioengineering and advancements in cellular biology.

Stem cell therapy for lungs disease.

Stem cell treatments for lung diseases may have taken a big step forward according to a pair of studies published earlier this month. The use of stem cell products including mesenchymal stem cells msc therapy from bone marrow adipose tissue or peripheral blood alone or in combination with platelet derived products e g. Platelet rich plasma lysate is considered investigational for the treatment of lung disease including but not limited to the following. Less progressed lung disease conditions require fewer stem cells to treat.

We organize our stem cell packages based on the size complexity and progression of your lung disease condition. Findings were presented in an oral presentation at the 2020 international society for cell gene therapy isct. Better characterization and methods of isolation of lung epithelial stem progenitor cells in both the mouse and human lung are needed in order to assess the influence of mscs and other cell therapy preparations on lung stem progenitor cell function and the potential for treating lung diseases. Remestemcel l mesoblast s lead candidate stem cell therapy for inflammatory diseases improves lung function and exercise capacity in people with chronic obstructive pulmonary disease copd and a high degree of inflammation data from a post hoc analysis of a phase 2 trial show.